NEIL SKOLNIK

8.3k total citations · 4 hit papers
109 papers, 3.4k citations indexed

About

NEIL SKOLNIK is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, NEIL SKOLNIK has authored 109 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Pulmonary and Respiratory Medicine and 16 papers in Physiology. Recurrent topics in NEIL SKOLNIK's work include Diabetes Treatment and Management (21 papers), Diabetes Management and Research (20 papers) and Asthma and respiratory diseases (12 papers). NEIL SKOLNIK is often cited by papers focused on Diabetes Treatment and Management (21 papers), Diabetes Management and Research (20 papers) and Asthma and respiratory diseases (12 papers). NEIL SKOLNIK collaborates with scholars based in United States, United Kingdom and Canada. NEIL SKOLNIK's co-authors include Lawrence Blonde, Stewart B. Harris, Kamlesh Khunti, Jay H. Shubrook, James J. Chamberlain, Alan P. Baptist, Michelle M. Cloutier, Wilson D. Pace, Edward G. Brooks and Craig A. Umscheid and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

NEIL SKOLNIK

93 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dietary Guidelines for Americans 2005

2005 927 citations NEIL SKOLNIK et al. profile →
2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group

2020 501 citations NEIL SKOLNIK et al. profile →
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician

2018 454 citations Lawrence Blonde, Kamlesh Khunti et al. Advances in Therapy profile →
Management of Hyperglycemia in Type 2 Diabetes

2012 379 citations NEIL SKOLNIK et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
NEIL SKOLNIK United States	20	869	848	814	669	398	109	3.4k
Martin Wiseman United Kingdom	27	809 0.9×	753 0.9×	916 1.1×	268 0.4×	329 0.8×	81	3.8k
Lital Keinan‐Boker Israel	35	505 0.6×	480 0.6×	743 0.9×	308 0.5×	492 1.2×	199	4.3k
Shih‐Han S. Huang Canada	16	1.1k 1.2×	670 0.8×	1.6k 1.9×	671 1.0×	424 1.1×	53	5.5k
B Shah India	14	638 0.7×	1.1k 1.3×	602 0.7×	336 0.5×	222 0.6×	21	2.8k
Ryne Paulose‐Ram United States	25	647 0.7×	597 0.7×	771 0.9×	544 0.8×	705 1.8×	35	4.2k
Diane Threapleton United Kingdom	22	584 0.7×	313 0.4×	909 1.1×	591 0.9×	259 0.7×	39	2.7k
Marianna Noale Italy	38	785 0.9×	358 0.4×	580 0.7×	331 0.5×	310 0.8×	158	3.9k
Suzanne C. Ho Hong Kong	37	547 0.6×	643 0.8×	990 1.2×	180 0.3×	552 1.4×	111	4.6k
Alipasha Meysamie Iran	32	511 0.6×	809 1.0×	579 0.7×	208 0.3×	599 1.5×	130	3.4k
Chinthanie Ramasundarahettige Canada	18	980 1.1×	643 0.8×	525 0.6×	317 0.5×	388 1.0×	33	3.7k

Countries citing papers authored by NEIL SKOLNIK

Since Specialization

Citations

This map shows the geographic impact of NEIL SKOLNIK's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NEIL SKOLNIK with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NEIL SKOLNIK more than expected).

Fields of papers citing papers by NEIL SKOLNIK

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by NEIL SKOLNIK. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NEIL SKOLNIK. The network helps show where NEIL SKOLNIK may publish in the future.

Co-authorship network of co-authors of NEIL SKOLNIK

This figure shows the co-authorship network connecting the top 25 collaborators of NEIL SKOLNIK. A scholar is included among the top collaborators of NEIL SKOLNIK based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with NEIL SKOLNIK. NEIL SKOLNIK is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

SKOLNIK, NEIL, et al.. (2026). Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease. Gastroenterology.

Chipps, Bradley E., et al.. (2025). Albuterol–budesonide rescue inhaler for asthma. Annals of Allergy Asthma & Immunology. 136(1). 54–60.e3.

SKOLNIK, NEIL, Barbara P. Yawn, Jaime Correia de Sousa, et al.. (2024). Best practice advice for asthma exacerbation prevention and management in primary care: an international expert consensus. npj Primary Care Respiratory Medicine. 34(1). 39–39.

Singh, Dave, MeiLan K. Han, Nathaniel M. Hawkins, et al.. (2024). Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review. Advances in Therapy. 41(6). 2151–2167. 34 indexed citations

Panettieri, Reynold A., Bradley E. Chipps, NEIL SKOLNIK, et al.. (2024). The Use of Albuterol/Budesonide as Reliever Therapy to Reduce Asthma Exacerbations. The Journal of Allergy and Clinical Immunology In Practice. 12(4). 882–888. 2 indexed citations

SKOLNIK, NEIL. (2023). In Honor of the Pig. JAMA Cardiology. 8(6). 521–521. 1 indexed citations

SKOLNIK, NEIL. (2023). Use of ICS and Fast-Acting Bronchodilators in Asthma: Past, Present, and Future. The Journal of Family Practice. 72(06 Supp). S61–S70. 2 indexed citations

SKOLNIK, NEIL, et al.. (2022). Integrating semaglutide into obesity management – a primary care perspective. Postgraduate Medicine. 134(sup1). 37–49. 1 indexed citations

SKOLNIK, NEIL, et al.. (2021). Importance of Early Screening and Diagnosis of Chronic Kidney Disease in Patients with Type 2 Diabetes. Diabetes Therapy. 12(6). 1613–1630. 18 indexed citations

10.

SKOLNIK, NEIL, Stefano Del Prato, Lawrence Blonde, G. R. Galstyan, & Julio Rosenstock. (2021). Translating iGlarLixi Evidence for the Management of Frequent Clinical Scenarios in Type 2 Diabetes. Advances in Therapy. 38(4). 1715–1731. 7 indexed citations

11.

Hurst, John R., NEIL SKOLNIK, Antonio Anzueto, et al.. (2020). Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life. European Journal of Internal Medicine. 73. 1–6. 109 indexed citations

12.

Dhand, Rajiv, et al.. (2018). Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease. Cleveland Clinic Journal of Medicine. 85(2 suppl 1). S19–S27. 10 indexed citations

13.

SKOLNIK, NEIL, et al.. (2018). Optimizing Insulin Therapy: Basal Insulin and Beyond.. PubMed. 67(10 Suppl). 1 indexed citations

14.

Blonde, Lawrence, et al.. (2018). Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician. Advances in Therapy. 35(11). 1763–1774. 454 indexed citations breakdown →

15.

SKOLNIK, NEIL, et al.. (2017). Reducing CV risk in diabetes: An ADA update.. PubMed. 66(5). 300–308. 5 indexed citations

16.

Johnson, Eric L., et al.. (2016). Diabetes update: Your guide to the latest ADA standards.. PubMed. 65(5). 310–8. 2 indexed citations

17.

SKOLNIK, NEIL & Deborah B. Horn. (2016). Answers to Clinical Questions in the Primary Care Management of People with Obesity: Lifestyle Management.. PubMed. 65(7 Suppl). S13–6. 3 indexed citations

18.

SKOLNIK, NEIL, et al.. (2016). Dapagliflozin in the treatment of patients with type 2 diabetes presenting with high baseline A1C. Postgraduate Medicine. 128(4). 356–363. 8 indexed citations

19.

SKOLNIK, NEIL. (2008). Essential Infectious Disease Topics for Primary Care. Humana Press eBooks. 3 indexed citations

20.

SKOLNIK, NEIL. (1989). Treatment of Croup. American journal of diseases of children. 143(9). 1045–1045. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact